DE69433140D1 - Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs - Google Patents

Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs

Info

Publication number
DE69433140D1
DE69433140D1 DE69433140T DE69433140T DE69433140D1 DE 69433140 D1 DE69433140 D1 DE 69433140D1 DE 69433140 T DE69433140 T DE 69433140T DE 69433140 T DE69433140 T DE 69433140T DE 69433140 D1 DE69433140 D1 DE 69433140D1
Authority
DE
Germany
Prior art keywords
treatment
prostate cancer
cyclophosphamide
metastasized prostate
expressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69433140T
Other languages
English (en)
Other versions
DE69433140T2 (de
Inventor
Lorne J Brandes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Manitoba Cancer Treatment and Research Foundation
Original Assignee
University of Manitoba
Manitoba Cancer Treatment and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manitoba , Manitoba Cancer Treatment and Research Foundation filed Critical University of Manitoba
Application granted granted Critical
Publication of DE69433140D1 publication Critical patent/DE69433140D1/de
Publication of DE69433140T2 publication Critical patent/DE69433140T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE69433140T 1993-12-27 1994-12-07 Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs Expired - Fee Related DE69433140T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/173,047 US5432168A (en) 1993-12-27 1993-12-27 Method of treatment of hormone-unresponsive metastatic prostate cancer
PCT/CA1994/000676 WO1995017887A1 (en) 1993-12-27 1994-12-07 Method of treatment of hormone-unresponsive metastatic prostate cancer
US173047 1998-10-15

Publications (2)

Publication Number Publication Date
DE69433140D1 true DE69433140D1 (de) 2003-10-16
DE69433140T2 DE69433140T2 (de) 2004-07-08

Family

ID=22630304

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433140T Expired - Fee Related DE69433140T2 (de) 1993-12-27 1994-12-07 Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs

Country Status (9)

Country Link
US (1) US5432168A (de)
EP (1) EP0737067B1 (de)
JP (1) JP3194525B2 (de)
AT (1) ATE249211T1 (de)
AU (1) AU699798B2 (de)
CA (1) CA2179377C (de)
DE (1) DE69433140T2 (de)
ES (1) ES2210278T3 (de)
WO (1) WO1995017887A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506876B1 (en) * 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US5863912A (en) * 1994-12-07 1999-01-26 Manitoba Cancer Treatment And Research Foundation Method of treatment of hormone-unresponsive metastiatic prostate cancer
US6241962B1 (en) 1996-06-24 2001-06-05 Dupont Pharmaceuticals Company Radiopharmaceutical compositions and matrices and uses thereof
US6498181B1 (en) 1999-01-06 2002-12-24 Maxim Pharmaceuticals Synergistic tumorcidal response induced by histamine
WO2009148623A2 (en) * 2008-06-05 2009-12-10 Stc.Unm Methods and related compositions for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829068A (en) * 1987-03-18 1989-05-09 University Of Manitoba Treatment of disorders of the gastro-intestinal tract
DE68924456T2 (de) * 1988-08-02 1996-05-30 Nissan Chemical Ind Ltd Mittel zur Verbesserung von Arzneimitteleffekten für Antitumormittel.
US4990538A (en) * 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
WO1992011035A1 (en) * 1990-12-17 1992-07-09 University Of Manitoba Improved treatment method for cancer
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
ES2210278T3 (es) 2004-07-01
CA2179377C (en) 2005-01-25
JPH09506902A (ja) 1997-07-08
AU699798B2 (en) 1998-12-17
AU1188995A (en) 1995-07-17
EP0737067A1 (de) 1996-10-16
WO1995017887A1 (en) 1995-07-06
US5432168A (en) 1995-07-11
CA2179377A1 (en) 1995-07-06
EP0737067B1 (de) 2003-09-10
ATE249211T1 (de) 2003-09-15
DE69433140T2 (de) 2004-07-08
JP3194525B2 (ja) 2001-07-30

Similar Documents

Publication Publication Date Title
KR960700076A (ko) 평활근 세포의 증식을 조절하기 위한 c-myc의 안티센스 억제(antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells)
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
NO20004911D0 (no) Antitumormiddel
ES2191068T3 (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
DE69021920D1 (de) Behandlung von Textilien mit Parfüm/Cyclodextrin-Komplexen.
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
EA199800391A1 (ru) Ингибирование роста опухоли антисмысловыми олигонуклеотидами к il-8 и il-8 рецептору
DE68913638D1 (de) Behandlung von wässerigen Systemen.
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
DE3767612D1 (de) Behandlung von eisen enthaltenden unterirdischen formationen.
DE69805202T2 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
ATE300292T1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
ES2082198T3 (es) Inhibidores de esteroide-sulfatasa.
ATE174785T1 (de) Behandlung von akne oder von folliculitis barbae
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69433140D1 (de) Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs
FR2092743A1 (en) Complete extraction of total flavanol gomers from plats -peripheral - venous activity
DE69103693D1 (de) Behandlung von unterirdischen Formationen.
DE69924979D1 (de) Behandlung von chronischen schmerzen
DE69218200D1 (de) Behandlung von leberkrebs
DE3674619D1 (de) Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis.
DE59803212D1 (de) Immobilisierung von vitamin-a-säure durch kationische polyelektrolyte
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee